INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Sep 16, 2008 |
VP, Regul Devel & Med Safety
|
VP, Regul Devel & Med Safety | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | $8.77 | 94,356 |
Sep 16, 2008 |
VP, Regul Devel & Med Safety
|
VP, Regul Devel & Med Safety | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | -- | -- |
Aug 20, 2008 |
VP, Regul Devel & Med Safety
|
VP, Regul Devel & Med Safety | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 34,840 | $6.50 | 45,254 |
Aug 20, 2008 |
VP, Regul Devel & Med Safety
|
VP, Regul Devel & Med Safety | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 34,840 | -- | 15,160 |
Dec 14, 2012 |
VP Regulat Dev & Med Safety
|
VP Regulat Dev & Med Safety | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 30,000 |
Dec 16, 2011 |
VP Regulatory Development and
|
VP Regulatory Development and | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,921 | -- | 1,921 |
Dec 16, 2011 |
VP Regulatory Development and
|
VP Regulatory Development and | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 28,079 | -- | 28,079 |
Dec 14, 2010 |
VP Regul Devel & Med Safety
|
VP Regul Devel & Med Safety | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,264 | -- | 3,264 |
Dec 14, 2010 |
VP Regul Devel & Med Safety
|
VP Regul Devel & Med Safety | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 26,736 | -- | 26,736 |
Dec 18, 2009 |
VP Regul Devel & Med Safety
|
VP Regul Devel & Med Safety | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,705 | -- | 4,705 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.